Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant sources » significant source (Expand Search), significant burden (Expand Search), significant burdens (Expand Search)
significant force » significant source (Expand Search), significant concern (Expand Search), significant effect (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant sources » significant source (Expand Search), significant burden (Expand Search), significant burdens (Expand Search)
significant force » significant source (Expand Search), significant concern (Expand Search), significant effect (Expand Search)
-
2481
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2482
-
2483
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2484
-
2485
-
2486
-
2487
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2488
-
2489
-
2490
-
2491
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2492
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2493
-
2494
-
2495
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2496
-
2497
-
2498
-
2499
-
2500